Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!

Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk


Quest Diagnostics launches three new test panels under its Quest Vantage brand. The lab-developed panels employ next-generation sequencing and a proprietary bioinformatics platform to identify genetic mutations associated with inherited risk of 15 cancers. According to the company, ~170K diagnoses are made in the U.S. each year of cancers that result from inherited genetic mutations. The tests only include genes that meet certain criteria such as a 2x increase in cancer risk, an association with a disease syndrome where cancer may occur and guideline support for genetic counseling. Quest will showcase the new panels at ASCO in Chicago.

https://www.fapvoice.com/wp-content/uploads/2016/08/4.jpg

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close